Logo image of PFE.DE

PFIZER INC (PFE.DE) Stock Fundamental Analysis

FRA:PFE - Deutsche Boerse Ag - US7170811035 - Common Stock - Currency: EUR

20.095  +0.05 (+0.27%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to PFE. PFE was compared to 50 industry peers in the Pharmaceuticals industry. PFE has a medium profitability rating, but doesn't score so well on its financial health evaluation. PFE has a bad growth rate and is valued cheaply.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

PFE had positive earnings in the past year.
PFE had a positive operating cash flow in the past year.
PFE had positive earnings in each of the past 5 years.
Each year in the past 5 years PFE had a positive operating cash flow.
PFE.DE Yearly Net Income VS EBIT VS OCF VS FCFPFE.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

1.2 Ratios

PFE has a Return On Assets (3.76%) which is in line with its industry peers.
Looking at the Return On Equity, with a value of 9.11%, PFE is in line with its industry, outperforming 54.00% of the companies in the same industry.
With a Return On Invested Capital value of 6.61%, PFE perfoms like the industry average, outperforming 48.00% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for PFE is below the industry average of 14.89%.
Industry RankSector Rank
ROA 3.76%
ROE 9.11%
ROIC 6.61%
ROA(3y)6.87%
ROA(5y)7.73%
ROE(3y)14.76%
ROE(5y)17.45%
ROIC(3y)9.9%
ROIC(5y)9.83%
PFE.DE Yearly ROA, ROE, ROICPFE.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

PFE has a Profit Margin of 12.62%. This is comparable to the rest of the industry: PFE outperforms 58.00% of its industry peers.
In the last couple of years the Profit Margin of PFE has declined.
PFE has a better Operating Margin (25.61%) than 78.00% of its industry peers.
PFE's Operating Margin has improved in the last couple of years.
PFE has a better Gross Margin (74.19%) than 64.00% of its industry peers.
In the last couple of years the Gross Margin of PFE has declined.
Industry RankSector Rank
OM 25.61%
PM (TTM) 12.62%
GM 74.19%
OM growth 3Y-9.04%
OM growth 5Y2.68%
PM growth 3Y-22.43%
PM growth 5Y-20.41%
GM growth 3Y6.02%
GM growth 5Y-1.61%
PFE.DE Yearly Profit, Operating, Gross MarginsPFE.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so PFE is still creating some value.
Compared to 1 year ago, PFE has more shares outstanding
PFE has more shares outstanding than it did 5 years ago.
PFE has a better debt/assets ratio than last year.
PFE.DE Yearly Shares OutstandingPFE.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B
PFE.DE Yearly Total Debt VS Total AssetsPFE.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B 200B

2.2 Solvency

PFE has an Altman-Z score of 1.98. This is not the best score and indicates that PFE is in the grey zone with still only limited risk for bankruptcy at the moment.
PFE has a Altman-Z score (1.98) which is comparable to the rest of the industry.
PFE has a debt to FCF ratio of 6.54. This is a slightly negative value and a sign of low solvency as PFE would need 6.54 years to pay back of all of its debts.
PFE has a Debt to FCF ratio of 6.54. This is comparable to the rest of the industry: PFE outperforms 50.00% of its industry peers.
PFE has a Debt/Equity ratio of 0.69. This is a neutral value indicating PFE is somewhat dependend on debt financing.
PFE has a Debt to Equity ratio (0.69) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF 6.54
Altman-Z 1.98
ROIC/WACC0.76
WACC8.73%
PFE.DE Yearly LT Debt VS Equity VS FCFPFE.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.3 Liquidity

PFE has a Current Ratio of 1.17. This is a normal value and indicates that PFE is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.17, PFE is not doing good in the industry: 70.00% of the companies in the same industry are doing better.
A Quick Ratio of 0.92 indicates that PFE may have some problems paying its short term obligations.
PFE has a Quick ratio of 0.92. This is comparable to the rest of the industry: PFE outperforms 46.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.17
Quick Ratio 0.92
PFE.DE Yearly Current Assets VS Current LiabilitesPFE.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

3

3. Growth

3.1 Past

PFE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 69.95%, which is quite impressive.
PFE shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.06% yearly.
PFE shows a small growth in Revenue. In the last year, the Revenue has grown by 7.42%.
Measured over the past years, PFE shows a quite strong growth in Revenue. The Revenue has been growing by 9.10% on average per year.
EPS 1Y (TTM)69.95%
EPS 3Y-11.06%
EPS 5Y1.06%
EPS Q2Q%530%
Revenue 1Y (TTM)7.42%
Revenue growth 3Y-7.84%
Revenue growth 5Y9.1%
Sales Q2Q%24.66%

3.2 Future

PFE is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -2.82% yearly.
The Revenue is expected to decrease by -1.89% on average over the next years.
EPS Next Y-3.97%
EPS Next 2Y-0.74%
EPS Next 3Y-0.97%
EPS Next 5Y-2.82%
Revenue Next Year-0.05%
Revenue Next 2Y-0.1%
Revenue Next 3Y-0.63%
Revenue Next 5Y-1.89%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
PFE.DE Yearly Revenue VS EstimatesPFE.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 20B 40B 60B 80B 100B
PFE.DE Yearly EPS VS EstimatesPFE.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 7.36 indicates a rather cheap valuation of PFE.
88.00% of the companies in the same industry are more expensive than PFE, based on the Price/Earnings ratio.
PFE's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.79.
A Price/Forward Earnings ratio of 7.65 indicates a rather cheap valuation of PFE.
Compared to the rest of the industry, the Price/Forward Earnings ratio of PFE indicates a rather cheap valuation: PFE is cheaper than 90.00% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.38. PFE is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 7.36
Fwd PE 7.65
PFE.DE Price Earnings VS Forward Price EarningsPFE.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

84.00% of the companies in the same industry are more expensive than PFE, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, PFE is valued a bit cheaper than the industry average as 72.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 13.18
EV/EBITDA 6.46
PFE.DE Per share dataPFE.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)6.93
EPS Next 2Y-0.74%
EPS Next 3Y-0.97%

6

5. Dividend

5.1 Amount

PFE has a Yearly Dividend Yield of 7.77%, which is a nice return.
Compared to an average industry Dividend Yield of 3.15, PFE pays a better dividend. On top of this PFE pays more dividend than 100.00% of the companies listed in the same industry.
PFE's Dividend Yield is rather good when compared to the S&P500 average which is at 2.51.
Industry RankSector Rank
Dividend Yield 7.77%

5.2 History

The dividend of PFE has a limited annual growth rate of 3.30%.
Dividend Growth(5Y)3.3%
Div Incr Years3
Div Non Decr Years3
PFE.DE Yearly Dividends per sharePFE.DE Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

118.44% of the earnings are spent on dividend by PFE. This is not a sustainable payout ratio.
The Dividend Rate of PFE has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP118.44%
EPS Next 2Y-0.74%
EPS Next 3Y-0.97%
PFE.DE Yearly Income VS Free CF VS DividendPFE.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B
PFE.DE Dividend Payout.PFE.DE Dividend Payout, showing the Payout Ratio.PFE.DE Dividend Payout.PayoutRetained Earnings

PFIZER INC

FRA:PFE (4/25/2025, 7:00:00 PM)

20.095

+0.05 (+0.27%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-04 2025-02-04/bmo
Earnings (Next)04-29 2025-04-29/bmo
Inst Owners67.49%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap113.97B
Analysts71.11
Price Target28.67 (42.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 7.77%
Yearly Dividend1.48
Dividend Growth(5Y)3.3%
DP118.44%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)51.1%
Min EPS beat(2)32.52%
Max EPS beat(2)69.69%
EPS beat(4)4
Avg EPS beat(4)46.88%
Min EPS beat(4)30.28%
Max EPS beat(4)69.69%
EPS beat(8)8
Avg EPS beat(8)53.03%
EPS beat(12)12
Avg EPS beat(12)40.38%
EPS beat(16)16
Avg EPS beat(16)34.9%
Revenue beat(2)2
Avg Revenue beat(2)9.27%
Min Revenue beat(2)1.31%
Max Revenue beat(2)17.22%
Revenue beat(4)4
Avg Revenue beat(4)6.3%
Min Revenue beat(4)1.31%
Max Revenue beat(4)17.22%
Revenue beat(8)5
Avg Revenue beat(8)3.32%
Revenue beat(12)8
Avg Revenue beat(12)3.78%
Revenue beat(16)10
Avg Revenue beat(16)3.34%
PT rev (1m)-2.8%
PT rev (3m)-6.99%
EPS NQ rev (1m)-2.05%
EPS NQ rev (3m)-4.82%
EPS NY rev (1m)0.09%
EPS NY rev (3m)2.19%
Revenue NQ rev (1m)-1.55%
Revenue NQ rev (3m)0.11%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)-0.1%
Valuation
Industry RankSector Rank
PE 7.36
Fwd PE 7.65
P/S 2.04
P/FCF 13.18
P/OCF 10.17
P/B 1.47
P/tB N/A
EV/EBITDA 6.46
EPS(TTM)2.73
EY13.59%
EPS(NY)2.63
Fwd EY13.06%
FCF(TTM)1.52
FCFY7.59%
OCF(TTM)1.98
OCFY9.83%
SpS9.86
BVpS13.67
TBVpS-5.54
PEG (NY)N/A
PEG (5Y)6.93
Profitability
Industry RankSector Rank
ROA 3.76%
ROE 9.11%
ROCE 9.56%
ROIC 6.61%
ROICexc 7.49%
ROICexgc 39.31%
OM 25.61%
PM (TTM) 12.62%
GM 74.19%
FCFM 15.46%
ROA(3y)6.87%
ROA(5y)7.73%
ROE(3y)14.76%
ROE(5y)17.45%
ROIC(3y)9.9%
ROIC(5y)9.83%
ROICexc(3y)11.35%
ROICexc(5y)11.61%
ROICexgc(3y)45.27%
ROICexgc(5y)42.26%
ROCE(3y)14.25%
ROCE(5y)14.1%
ROICexcg growth 3Y-11.81%
ROICexcg growth 5Y26.33%
ROICexc growth 3Y-25.3%
ROICexc growth 5Y9.29%
OM growth 3Y-9.04%
OM growth 5Y2.68%
PM growth 3Y-22.43%
PM growth 5Y-20.41%
GM growth 3Y6.02%
GM growth 5Y-1.61%
F-Score8
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF 6.54
Debt/EBITDA 2.6
Cap/Depr 41.48%
Cap/Sales 4.57%
Interest Coverage 5.05
Cash Conversion 54.68%
Profit Quality 122.46%
Current Ratio 1.17
Quick Ratio 0.92
Altman-Z 1.98
F-Score8
WACC8.73%
ROIC/WACC0.76
Cap/Depr(3y)55.83%
Cap/Depr(5y)55.63%
Cap/Sales(3y)4.83%
Cap/Sales(5y)4.9%
Profit Quality(3y)143.88%
Profit Quality(5y)138.86%
High Growth Momentum
Growth
EPS 1Y (TTM)69.95%
EPS 3Y-11.06%
EPS 5Y1.06%
EPS Q2Q%530%
EPS Next Y-3.97%
EPS Next 2Y-0.74%
EPS Next 3Y-0.97%
EPS Next 5Y-2.82%
Revenue 1Y (TTM)7.42%
Revenue growth 3Y-7.84%
Revenue growth 5Y9.1%
Sales Q2Q%24.66%
Revenue Next Year-0.05%
Revenue Next 2Y-0.1%
Revenue Next 3Y-0.63%
Revenue Next 5Y-1.89%
EBIT growth 1Y114.49%
EBIT growth 3Y-16.17%
EBIT growth 5Y12.02%
EBIT Next Year23.03%
EBIT Next 3Y6.03%
EBIT Next 5Y4.91%
FCF growth 1Y105.2%
FCF growth 3Y-30.95%
FCF growth 5Y-0.32%
OCF growth 1Y46.48%
OCF growth 3Y-26.87%
OCF growth 5Y0.25%